The potential role of uric acid in women with polycystic ovary syndrome

References

• Stephen F. Polycystic ovary syndrome. N. Engl. J. Med. 1995;333:1.
   Web of Science ®Google Scholar
• Macut D, Simic T, Lissounov A, et al. Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress. Exp Clin Endocrinol Diabetes. 2011;119(7):451–10. doi:10.1055/s-0031-1279740.
   PubMed Web of Science ®Google Scholar
• Durmus U, Duran C, Ecirli S. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory ­parameters. J Endocrinol Invest. 2017;40(5):487–497. doi:10.1007/s40618-016-0582-x.
   Web of Science ®Google Scholar
• Mu L, Pan J, Yang L, et al. Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome. Reprod Biol Endocrinol. 2018;16(1):104. doi:10.1186/s12958-018-0419-x.
   PubMedGoogle Scholar
• Moran LJ, Misso ML, Wild RA, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and Meta-Analysis. Hum Reprod Update. 2010;16(4):347–363. doi:10.1093/humupd/dmq001.
   PubMed Web of Science ®Google Scholar
• Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med. 2001;111(8):607–613. doi:10.1016/S0002-9343(01)00948-2.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Lanaspa MA, Gaucher EA. Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations. Semin Nephrol. 2011;31(5):394–399. doi:10.1016/j.semnephrol.2011.08.002.
   Web of Science ®Google Scholar
• Jakše B, Jakše B, Pajek M, et al. Uric acid and Plant-Based nutrition. Nutrients. 2019;11(8):1736. doi:10.3390/nu11081736.
   Web of Science ®Google Scholar
• Choi HK, Atkinson K, Karlson EW, et al. Purine-Rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350(11):1093–1103. doi:10.1056/NEJMoa035700.
   PubMed Web of Science ®Google Scholar
• Khitan Z, Kim DH. Fructose: a key factor in the development of metabolic syndrome and hypertension. J Nutr Metab. 2013;2013:682673–682612. doi:10.1155/2013/682673.
   PubMedGoogle Scholar
• Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290(3):F625–F631. doi:10.1152/ajprenal.00140.2005.
   PubMed Web of Science ®Google Scholar
• Neogi T, Chen C, Niu J, et al. Alcohol quantity and type on risk of recurrent gout attacks: an Internet-Based Case-Crossover study. Am J Med. 2014;127(4):311–318. doi:10.1016/j.amjmed.2013.12.019.
   PubMed Web of Science ®Google Scholar
• Wang W, Bhole VM, Krishnan E. Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the framingham heart study. BMJ Open. 2015;5(4):e006843–e006843. doi:10.1136/bmjopen-2014-006843.
   Web of Science ®Google Scholar
• Major TJ, Topless RK, Dalbeth N, et al. Evaluation of the diet wide contribution to serum urate levels: meta-Analysis of population based cohorts. BMJ. 2018;363:k3951. doi:10.1136/bmj.k3951.
   PubMed Web of Science ®Google Scholar
• Messerli FH, Frohlich ED, Dreslinski GR, et al. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med. 1980;93(6):817–821. doi:10.7326/0003-4819-93-6-817.
   PubMed Web of Science ®Google Scholar
• Yip K, Cohen RE, Pillinger MH. Asymptomatic hyperuricemia: is it really asymptomatic? Curr Opin Rheumatol. 2020;32(1):71–79. doi:10.1097/BOR.0000000000000679.
   PubMed Web of Science ®Google Scholar
• Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50(1):113–116. doi:10.1210/jcem-50-1-113.
   PubMed Web of Science ®Google Scholar
• Mazidi M, Katsiki N, Mikhailidis DP, et al. The link between insulin resistance parameters and serum uric acid is mediated by adiposity. Atherosclerosis. 2018;270:180–186. doi:10.1016/j.atherosclerosis.2017.12.033.
   PubMed Web of Science ®Google Scholar
• Novak S, Melkonian AK, Patel PA, et al. Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use. Curr Med Res Opin. 2007;23(3):623–630. doi:10.1185/030079906X167651.
   PubMed Web of Science ®Google Scholar
• Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007;120(5):442–447. doi:10.1016/j.amjmed.2006.06.040.
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Korenman SG. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril. 2003;80(2):255–258. doi:10.1016/S0015-0282(03)00734-9.
   PubMed Web of Science ®Google Scholar
• El Ridi R, Tallima H. Physiological functions and pathogenic potential of uric acid: A review. J Adv Res. 2017;8(5):487–493. doi: 10.1016/j.jare.2017.03.003.
   PubMed Web of Science ®Google Scholar
• Nishino T, Okamoto K. Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout. J Biol Inorg Chem. 2015;20(2):195–207. doi:10.1007/s00775-014-1210-x.
   Web of Science ®Google Scholar
• Mandal AK, Mount DB. The molecular physiology of uric acid homeostasis. Annu Rev Physiol. 2015;77(1):323–345. doi:10.1146/annurev-physiol-021113-170343.
   PubMedGoogle Scholar
• Oda M, Satta Y, Takenaka O, et al. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol. 2002;19(5):640–653. doi:10.1093/oxfordjournals.molbev.a004123.
   PubMed Web of Science ®Google Scholar
• Xu L, Shi Y, Zhuang S, et al. Recent advances on uric acid transporters. Oncotarget. 2017;8(59):100852–100862. doi:10.18632/oncotarget.20135.
   PubMedGoogle Scholar
• Sorensen LB. Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum. 1965;8(5):694–706. doi:10.1002/art.1780080429.
   PubMedGoogle Scholar
• Maiuolo J, Oppedisano F, Gratteri S, et al. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8–14. doi:10.1016/j.ijcard.2015.08.109.
   PubMed Web of Science ®Google Scholar
• Montague CT, O’Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes. 2000;49(6):883–888. doi:10.2337/diabetes.49.6.883.
   PubMed Web of Science ®Google Scholar
• Luque-Ramírez M, Alvarez-Blasco F, Uriol Rivera MG, et al. Serum uric acid concentration as non-Classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with Ethinyl-Estradiol plus cyproterone acetate versus metformin. Hum Reprod. 2008;23(7):1594–1601. doi:10.1093/humrep/den095.
   PubMed Web of Science ®Google Scholar
• Choi HK, McCormick N, Lu N, et al. Population impact attributable to modifiable risk factors for hyperuricemia. Arthritis Rheumatol. 2020;72(1):157–165. doi:10.1002/art.41067.
   PubMed Web of Science ®Google Scholar
• Zhang Y,Cai M,Dilimulati D, et al. Correlation between serum uric acid and body fat distribution in patients with polycystic ovary syndrome. Front Endocrinol. 2021;12:782808 10.3389/fendo.2021.782808
   PubMed Web of Science ®Google Scholar
• Zhu C, Cui R, Gao M, et al. The associations of serum uric acid with obesity-related acanthosis nigricans and related metabolic indices. Int J Endocrinol. 2017;2017:5438157. doi:10.1155/2017/5438157.
   Web of Science ®Google Scholar
• Choi HK, Atkinson K, Karlson EW, et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men. Arch Intern Med. 2005;165(7):742–748. doi:10.1001/archinte.165.7.742.
   PubMed Web of Science ®Google Scholar
• Rathmann W, Haastert B, Icks A, et al. Ten-Year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study. Eur J Epidemiol. 2007;22(7):439–445. doi:10.1007/s10654-007-9132-3.
   PubMed Web of Science ®Google Scholar
• Chu NF, Wang DJ, Liou SH, et al. Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan. Eur J Epidemiol. 2000;16(1):13–17. doi:10.1023/a:1007654507054.
   PubMed Web of Science ®Google Scholar
• Ogura T, Matsuura K, Matsumoto Y, et al. Recent trends of hyperuricemia and obesity in japanese male adolescents, 1991 through 2002. Metabolism. 2004;53(4):448–453. doi:10.1016/j.metabol.2003.11.017.
   PubMed Web of Science ®Google Scholar
• Cook DG, Shaper AG, Thelle DS, et al. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J. 1986;62(733):1001–1006. doi:10.1136/pgmj.62.733.1001.
   Web of Science ®Google Scholar
• Yamashita S, Matsuzawa Y, Tokunaga K, et al. Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a Low-Calorie diet. Int J Obes. 1986;10(4):255–264.
   PubMed Web of Science ®Google Scholar
• Martinez-Hervas S, Real JT, Ivorra C, et al. Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipidemia. Nutr Metab Cardiovasc Dis. 2010;20(10):734–739. doi:10.1016/j.numecd.2009.06.003.
   PubMed Web of Science ®Google Scholar
• Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and Meta-Analysis. Am J Med. 2009;122(3):248–256.e5. doi:10.1016/j.amjmed.2008.09.041.
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Chen P, White M, et al. Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study. Ann Rheum Dis. 2014;73(5):797–802. doi:10.1136/annrheumdis-2013-203970.
   PubMed Web of Science ®Google Scholar
• Lu J, Bai Z, Chen Y, et al. Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis. Rheumatology. 2021;60(8):3628–3634. doi:10.1093/rheumatology/keaa822.
   Web of Science ®Google Scholar
• Maglio C, Peltonen M, Neovius M, et al. Effects of bariatric surgery on gout incidence in the swedish obese subjects study: a non-Randomised, prospective, controlled intervention trial. Ann Rheum Dis. 2017;76(4):688–693. doi:10.1136/annrheumdis-2016-209958.
   PubMed Web of Science ®Google Scholar
• Yokose C, McCormick N, Rai SK, et al. Effects of Low-Fat, mediterranean, or Low-Carbohydrate weight loss diets on serum urate and cardiometabolic risk factors: a secondary analysis of the dietary intervention randomized controlled trial (DIRECT). Diabetes Care. 2020;43(11):2812–2820. doi:10.2337/dc20-1002.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Harris RP, Forciea MA, Clinical Guidelines Committee of the American College of Physicians., et al. For the clinical guidelines committee of the American college of physicians management of acute and recurrent gout: a clinical practice guideline from the American college of physicians. Ann Intern Med. 2017;166(1):58–68. doi:10.7326/M16-0570.
   PubMed Web of Science ®Google Scholar
• Hamburger M, Baraf HSB, Adamson TC, et al. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia. Postgrad Med. 2011;123(6 Suppl 1):3–36. doi:10.3810/pgm.2011.11.2511.
   PubMedGoogle Scholar
• Yamanaka H, Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids. 2011;30(12):1018–1029. doi:10.1080/15257770.2011.596496.
   PubMed Web of Science ®Google Scholar
• Richette P, Doherty M, Pascual E, et al. 2016 Updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29–42. doi:10.1136/annrheumdis-2016-209707.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhang Y, Choi HK. The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the multiple risk factor intervention trial. Rheumatology (Oxford). 2010;49(12):2391–2399. doi:10.1093/rheumatology/keq256.
   PubMed Web of Science ®Google Scholar
• Kawano Y, Okuda N, Minami J, et al. Effects of a Low-Energy diet and an insulin-sensitizing agent on ambulatory blood pressure in overweight hypertensive patients. J Hypertens. 2000;18(10):1451–1455. doi:10.1097/00004872-200018100-00013.
   Web of Science ®Google Scholar
• Song P, Wang H, Xia W, et al. Prevalence and correlates of hyperuricemia in the Middle-Aged and older adults in China. Sci Rep. 2018;8(1):4314. doi:10.1038/s41598-018-22570-9.
   PubMed Web of Science ®Google Scholar
• Trifirò G, Morabito P, Cavagna L, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis. 2013;72(5):694–700. doi:10.1136/annrheumdis-2011-201254.
   PubMed Web of Science ®Google Scholar
• Akasaka H, Yoshida H, Takizawa H, et al. The impact of elevation of serum uric acid level on the natural history of glomerular filtration rate (GFR) and its sex difference. Nephrol Dial Transplant. 2014;29(10):1932–1939. doi:10.1093/ndt/gfu197.
   PubMed Web of Science ®Google Scholar
• Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and Meta-Analysis. BioMed Res. Int. 2015;2015:1–12. doi:10.1155/2015/762820.
   Web of Science ®Google Scholar
• Barbieri L, Verdoia M, Schaffer A, et al. Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: a Single-Centre study. Atherosclerosis. 2015;241(1):241–248. doi:10.1016/j.atherosclerosis.2015.03.030.
   PubMed Web of Science ®Google Scholar
• Mumford SL, Dasharathy SS, Pollack AZ, et al. Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. Hum Reprod. 2013;28(7):1853–1862. doi:10.1093/humrep/det085.
   PubMed Web of Science ®Google Scholar
• Jung JH, Song GG, Lee YH, et al. Serum uric acid levels and hormone therapy type: a retrospective cohort study of postmenopausal women. Menopause. 2018;25(1):77–81. doi:10.1097/GME.0000000000000953.
   PubMed Web of Science ®Google Scholar
• Adamopoulos D, Vlassopoulos C, Seitanides B, et al. The relationship of sex steroids to uric acid levels in plasma and urine. Acta Endocrinol (Copenh). 1977;85(1):198–208. doi:10.1530/acta.0.0850198.
   PubMedGoogle Scholar
• Wingrove CS, Walton C, Stevenson JC. The effect of menopause on serum uric acid levels in non-obese healthy women. Metabolism. 1998;47(4):435–438. doi:10.1016/S0026-0495(98)90056-7.
   PubMed Web of Science ®Google Scholar
• Hak AE, Curhan GC, Grodstein F, et al. Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis. 2010;69(7):1305–1309. doi:10.1136/ard.2009.109884.
   PubMed Web of Science ®Google Scholar
• Sumino H, Ichikawa S, Kanda T, et al. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet. 1999;354(9179):650. doi:10.1016/S0140-6736(99)92381-4.
   PubMed Web of Science ®Google Scholar
• Ioannou GN, Boyko EJ. Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality. Atherosclerosis. 2013;226(1):220–227. doi:10.1016/j.atherosclerosis.2012.10.044.
   PubMed Web of Science ®Google Scholar
• Darlington LG, Ainsworth JG, Blight A, et al. Changes in urate metabolism after castration of patients suffering from carcinoma of the prostate. In: Harkness RA, Elion GB, Zöllner N, editors. Purine and pyrimidine metabolism in man VII. Advances in Experimental Medicine and Biology. Boston, MA: Springer US; 1991. Vol. 309A, pp. 235–238. doi:10.1007/978-1-4899-2638-8_53.
   Google Scholar
• Pizzichini M, Di Stefano A, Resconi G, et al. Influence of testosterone on purine nucleotide turnover in rat kidney. Horm Metab Res. 1990;22(6):334–338. doi:10.1055/s-2007-1004914.
   Web of Science ®Google Scholar
• Hosoyamada M, Takiue Y, Shibasaki T, et al. The effect of testosterone upon the urate reabsorptive transport system in mouse kidney. Nucleosides Nucleotides Nucleic Acids. 2010;29(7):574–579. doi:10.1080/15257770.2010.494651.
   PubMed Web of Science ®Google Scholar
• Puig JG, Mateos FA, Ramos TH, et al. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2). Adv Exp Med Biol. 1986;195(Pt A):317–323. doi:10.1007/978-1-4684-5104-7_54.
   Google Scholar
• Yahyaoui R, Esteva I, Haro-Mora JJ, et al. Effect of long-term administration of Cross-Sex hormone therapy on serum and urinary uric acid in transsexual persons. J Clin Endocrinol Metab. 2008;
   Google Scholar
• Woodward OM, Köttgen A, Coresh J, et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A. 2009;106(25):10338–10342. doi:10.1073/pnas.0901249106.
   PubMed Web of Science ®Google Scholar
• Hoque KM, Dixon EE, Lewis RM, et al. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion. Nat Commun. 2020;11(1):2767. doi:10.1038/s41467-020-16525-w.
   PubMed Web of Science ®Google Scholar
• Ee PLR, Kamalakaran S, Tonetti D, et al. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 2004;64(4):1247–1251. doi:10.1158/0008-5472.can-03-3583.
   PubMed Web of Science ®Google Scholar
• Imai Y, Ishikawa E, Asada S, et al. Estrogen-Mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res. 2005;65(2):596–604.
   PubMed Web of Science ®Google Scholar
• Stener-Victorin E, Padmanabhan V, Walters KA, et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev. 2020;41(4):bnaa010. doi:10.1210/endrev/bnaa010.
   PubMed Web of Science ®Google Scholar
• Cassano E, Tosto L, Balestrieri M, et al. Antioxidant defense in the follicular fluid of water buffalo. Cell Physiol Biochem. 1999;9(2):106–116. doi:10.1159/000016307.
   PubMedGoogle Scholar
• Halliwell B. Free radicals and antioxidants: a personal view. Nutr Rev. 1994;52(8 Pt 1):253–265. doi:10.1111/j.1753-4887.1994.tb01453.x.
   PubMed Web of Science ®Google Scholar
• Lavy G, Behrman HR, Polan ML. Purine levels and metabolism in human follicular fluid. Hum Reprod. 1990;5(5):529–532. doi:10.1093/oxfordjournals.humrep.a137136.
   Web of Science ®Google Scholar
• Alexiou M, Leese HJ. Purine utilisation, de novo synthesis and degradation in mouse preimplantation embryos. Development. 1992;114(1):185–192. doi:10.1242/dev.114.1.185.
   Web of Science ®Google Scholar
• Wen X, Perrett D, Jones N, et al. High follicular fluid adenosine levels may be pivotal in the metabolism and recycling of adenosine nucleotides in the human follicle. Metabolism. 2010;59(8):1145–1155. doi:10.1016/j.metabol.2009.09.037.
   Web of Science ®Google Scholar
• Ruebel ML, Piccolo BD, Mercer KE, et al. Obesity leads to distinct metabolomic signatures in follicular fluid of women undergoing in vitro fertilization. Am J Physiol Endocrinol Metab. 2019;316(3):E383–E396. doi:10.1152/ajpendo.00401.2018.
   Web of Science ®Google Scholar
• Herman JB,Goldbourt U. Uric acid and diabetes: observations in a population study. Lancet. 1982;2(8292):240–243. doi:10.1016/s0140-6736(82)90324-5 6124672
   PubMed Web of Science ®Google Scholar
• Tuomilehto J,Zimmet P,Wolf E, et al. Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol. 1988;127(2):321–336. doi:10.1093/oxfordjournals.aje.a114807 3337086
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Tatara K, Nakamura K, et al. Risk factors for the incidence of hyperuricaemia: a 6-Year longitudinal study of Middle-Aged japanese men. Int J Epidemiol. 1999;28(5):888–893. doi:10.1093/ije/28.5.888.
   PubMed Web of Science ®Google Scholar
• Modan M, Halkin H, Karasik A, et al. Elevated serum uric acid ? A facet of hyperinsulinaemia. Diabetologia. 1987;30(9):713–718. doi:10.1007/BF00296994.
   PubMed Web of Science ®Google Scholar
• Rathmann W, Funkhouser E, Dyer AR, et al. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Ann Epidemiol. 1998;8(4):250–261. doi:10.1016/S1047-2797(97)00204-4.
   PubMed Web of Science ®Google Scholar
• Chou P, Lin KC, Lin HY, et al. Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes. J Rheumatol. 2001;28(3):571–576.
   PubMed Web of Science ®Google Scholar
• Kono S, Shinchi K, Imanishi K, et al. Behavioural and biological correlates of serum uric acid: a study of Self-Defence officials in Japan. Int J Epidemiol. 1994;23(3):517–522. doi:10.1093/ije/23.3.517.
   Web of Science ®Google Scholar
• Okada M, Ueda K, Omae T, et al. The relationship of serum uric acid to hypertension and ischemic heart disease in hisayama population, Japan. J Chronic Dis. 1982;35(3):173–178. doi:10.1016/0021-9681(82)90137-0.
   Google Scholar
• Facchini F, Chen YD, Hollenbeck CB, et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266(21):3008–3011.
   PubMed Web of Science ®Google Scholar
• Muscelli E, Natali A, Bianchi S, et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens. 1996;9(8):746–752. doi:10.1016/0895-7061(96)00098-2.
   PubMed Web of Science ®Google Scholar
• Maaten JCT, Voorburg A, Heine RJ, et al. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond). 1997;92(1):51–58. doi:10.1042/cs0920051.
   Web of Science ®Google Scholar
• Dessein PH, Shipton EA, Stanwix AE, et al. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis. 2000;59(7):539–543. doi:10.1136/ard.59.7.539.
   PubMed Web of Science ®Google Scholar
• Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate–anion exchanger that regulates blood urate levels. Nature. 2002;417(6887):447–452. doi:10.1038/nature742.
   PubMed Web of Science ®Google Scholar
• Kuwabara M, Borghi C, Cicero AFG, et al. Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: a Five-Year cohort study in Japan. Int J Cardiol. 2018;261:183–188. doi:10.1016/j.ijcard.2018.03.045.
   PubMed Web of Science ®Google Scholar
• Lanaspa MA, Sanchez-Lozada LG, Choi Y-J, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress. J Biol Chem. 2012;287(48):40732–40744. doi:10.1074/jbc.M112.399899.
   PubMed Web of Science ®Google Scholar
• Cicerchi C, Li N, Kratzer J, et al. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids. Faseb J. 2014;28(8):3339–3350. doi:10.1096/fj.13-243634.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Corton J, Ching YP, et al. Regulation of lipid metabolism by the AMP-Activated protein kinase. Biochem Soc Trans. 1997;25(4):1229–1231. doi:10.1042/bst0251229.
   PubMed Web of Science ®Google Scholar
• Barroso E, Rodríguez-Calvo R, Serrano-Marco L, et al. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation. Endocrinology. 2011;152(5):1848–1859. doi:10.1210/en.2010-1468.
   PubMed Web of Science ®Google Scholar
• Tsushima Y, Nishizawa H, Tochino Y, et al. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem. 2013;288(38):27138–27149. doi:10.1074/jbc.M113.485094.
   PubMed Web of Science ®Google Scholar
• Sautin YY, Nakagawa T, Zharikov S, et al. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol. 2007;293(2):C584–C596. doi:10.1152/ajpcell.00600.2006.
   PubMed Web of Science ®Google Scholar
• Oberbach A, Neuhaus J, Schlichting N, et al. Sleeve gastrectomy reduces xanthine oxidase and uric acid in a rat model of morbid obesity. Surg Obes Relat Dis. 2014;10(4):684–690. doi:10.1016/j.soard.2013.12.010.
   Web of Science ®Google Scholar
• Nikkilä EA. Control of plasma and liver triglyceride kinetics by carbohydrate metabolism and insulin. Adv Lipid Res. 1969;7:63–134. doi:10.1016/b978-0-12-024907-7.50009-9.
   PubMedGoogle Scholar
• van den Berghe G, Bronfman M, Vanneste R, et al. The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase. Biochem J. 1977;162(3):601–609. doi:10.1042/bj1620601.
   Web of Science ®Google Scholar
• Gresser U, Gathof BS, Gross M. Benzbromarone and fenofibrate are lipid lowering and uricosuric: a possible key to metabolic syndrome? Adv Exp Med Biol. 1994;370:87–90. doi:10.1007/978-1-4615-2584-4_22.
   Google Scholar
• Baldwin W, McRae S, Marek G, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011;60(4):1258–1269. doi:10.2337/db10-0916.
   PubMed Web of Science ®Google Scholar
• Athyros VG, Elisaf M, Papageorgiou AA, et al. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and Coronary-Heart-disease evaluation (GREACE) study. Am J Kidney Dis. 2004;43(4):589–599. doi:10.1053/j.ajkd.2003.12.023.
   PubMed Web of Science ®Google Scholar
• Milionis HJ, Kakafika AI, Tsouli SG, et al. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J. 2004;
   Google Scholar
• Agarwal A, Aponte-Mellado A, Premkumar BJ, et al. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10(1):49. doi:10.1186/1477-7827-10-49.
   PubMedGoogle Scholar
• Griendling KK, Camargo LL, Rios FJ, et al. Oxidative stress and hypertension. Circ Res. 2021;128(7):993–1020. doi:10.1161/CIRCRESAHA.121.318063.
   PubMed Web of Science ®Google Scholar
• Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944–948. doi:10.1038/nature04634.
   PubMed Web of Science ®Google Scholar
• Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals. Cancer Lett. 2017;387:95–105. doi:10.1016/j.canlet.2016.03.042.
   PubMed Web of Science ®Google Scholar
• Apel K, Hirt H. REACTIVE OXYGEN SPECIES: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol. 2004;55(1):373–399. doi:10.1146/annurev.arplant.55.031903.141701.
   PubMed Web of Science ®Google Scholar
• Ames BN, Cathcart R, Schwiers E, et al. Uric acid provides an antioxidant defense in humans against oxidant- and Radical-Caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858–6862. doi:10.1073/pnas.78.11.6858.
   PubMed Web of Science ®Google Scholar
• Sautin YY, Johnson RJ. Uric acid: the Oxidant-Antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008;27(6):608–619. doi:10.1080/15257770802138558.
   PubMed Web of Science ®Google Scholar
• Ali N, Perveen R, Rahman S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on bangladeshi adults. Plos One. 2018;13(11):e0206850. doi:10.1371/journal.pone.0206850.
   PubMed Web of Science ®Google Scholar
• Kuwabara M, Kuwabara R, Niwa K, et al. Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in japanese and American subjects. Nutrients. 2018;10(8):1011. doi:10.3390/nu10081011.
   PubMed Web of Science ®Google Scholar
• Lima WG, Martins-Santos MES, Chaves VE. Uric acid as a modulator of glucose and lipid metabolism. Biochimie. 2015;116:17–23. doi:10.1016/j.biochi.2015.06.025.
   PubMed Web of Science ®Google Scholar
• Zeng C, Guo B, Wan Y, et al. The role of lipid profile in the relationship between particulate matters and hyperuricemia: a prospective population study. Environ Res. 2022;214(Pt 2):113865. doi:10.1016/j.envres.2022.113865.
   Google Scholar
• Cassano V, Crescibene D, Hribal ML, et al. Uric acid and vascular damage in essential hypertension: role of insulin resistance. Nutrients. 2020;12(9):2509. doi:10.3390/nu12092509.
   Web of Science ®Google Scholar
• Borghi C, Rosei EA, Bardin T, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33(9):1729–1741; discussion 1741. doi:10.1097/HJH.0000000000000701.
   PubMed Web of Science ®Google Scholar
• Berg AH, Lin Y, Lisanti MP, et al. Adipocyte differentiation induces dynamic changes in NF-κB expression and activity. Am J Physiol Endocrinol Metab. 2004;287(6):E1178–E1188. doi:10.1152/ajpendo.00002.2004.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–1761. doi:10.1172/JCI21625.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Nakagawa T, Sanchez-Lozada LG, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013;62(10):3307–3315. doi:10.2337/db12-1814.
   PubMed Web of Science ®Google Scholar
• Gherghina M-E, Peride I, Tiglis M, et al. Uric acid and oxidative stress—relationship with cardiovascular, metabolic, and renal impairment. Int J Mol Sci. 2022;23(6):3188. doi:10.3390/ijms23063188.
   PubMed Web of Science ®Google Scholar
• Bagnati M, Perugini C, Cau C, et al. When and why a Water-Soluble antioxidant becomes pro-Oxidant during Copper-Induced Low-Density lipoprotein oxidation: a study using uric acid. Biochem. J. 1999;340(1):143–152. doi:10.1042/0264-6021:3400143.
   PubMedGoogle Scholar
• Bakker SJL, Gans ROB, ter Maaten JC, et al. The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. Atherosclerosis. 2001;155(2):283–290. doi:10.1016/S0021-9150(00)00745-0.
   Web of Science ®Google Scholar
• Balakrishnan VS, Coles GA, Williams JD. A potential role for endogenous adenosine in control of human glomerular and tubular function. Am J Physiol. 1993;265(4 Pt 2):F504–F510. doi:10.1152/ajprenal.1993.265.4.F504.
   Google Scholar
• Fransen R, Koomans HA. Adenosine and renal sodium handling: direct natriuresis and renal Nerve-Mediated antinatriuresis. J Am Soc Nephrol. 1995;6(5):1491–1497. doi:10.1681/ASN.V651491.
   Web of Science ®Google Scholar
• Balakrishnan VS, Coles GA, Williams JD. Effects of intravenous adenosine on renal function in healthy human subjects. Am J Physiol. 1996;271(2 Pt 2):F374–F381. doi:10.1152/ajprenal.1996.271.2.F374.
   Google Scholar
• Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020;30(7):399–404. doi:10.1016/j.tcm.2019.08.010.
   PubMed Web of Science ®Google Scholar
• Palomba S, de Wilde MA, Falbo A, et al. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575–592. doi:10.1093/humupd/dmv029.
   PubMed Web of Science ®Google Scholar
• Boomsma CM, Eijkemans MJC, Hughes EG, et al. A Meta-Analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673–683. doi:10.1093/humupd/dml036.
   PubMed Web of Science ®Google Scholar
• Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42(4):474–480. doi:10.1161/01.HYP.0000091371.53502.D3.
   PubMed Web of Science ®Google Scholar
• Koratala A, Singhania G, Alquadan KF, et al. Serum uric acid exhibits inverse relationship with estimated glomerular filtration rate. Nephron. 2016;134(4):231–237. doi:10.1159/000448629.
   PubMed Web of Science ®Google Scholar
• Kuwabara M, Bjornstad P, Hisatome I, et al. Elevated serum uric acid level predicts rapid decline in kidney function. Am J Nephrol. 2017;45(4):330–337. doi:10.1159/000464260.
   PubMed Web of Science ®Google Scholar
• Sidoti A, Nigrelli S, Rosati A, et al. Body mass index, fat free mass, uric acid, and renal function as blood pressure levels determinants in young adults: BMI, FFM, uric acid, eGFR: BP determinants in young adults. Nephrology (Carlton). 2017;22(4):279–285. doi:10.1111/nep.12763.
   Web of Science ®Google Scholar
• Mehta T, Nuccio E, McFann K, et al. Association of uric acid with vascular stiffness in the framingham heart study. Am J Hypertens. 2015;28(7):877–883. doi:10.1093/ajh/hpu253.
   PubMed Web of Science ®Google Scholar
• Kuwabara M, Niwa K, Hisatome I, et al. Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-Year japanese cohort study. Hypertension. 2017;69(6):1036–1044. doi:10.1161/HYPERTENSIONAHA.116.08998.
   PubMed Web of Science ®Google Scholar
• Roumeliotis S, Roumeliotis A, Dounousi E, et al. Dietary antioxidant supplements and uric acid in chronic kidney disease: a review. Nutrients. 2019;11(8):1911. doi:10.3390/nu11081911.
   PubMed Web of Science ®Google Scholar
• Carter J, Child A. Serum uric acid levels in normal pregnancy. Aust N Z J Obstet Gynaecol. 1989;29(3 Pt 2):313–314. doi:10.1111/j.1479-828X.1989.tb01751.x.
   Web of Science ®Google Scholar
• Laughon SK, Catov J, Provins T, et al. Elevated First-Trimester uric acid concentrations are associated with the development of gestational diabetes. Am J Obstet Gynecol. 2009;201(4):402.e1-402–e5. doi:10.1016/j.ajog.2009.06.065.
   Web of Science ®Google Scholar
• Weissgerber TL, Milic NM, Turner ST, et al. Uric acid: a missing link between hypertensive pregnancy disorders and future cardiovascular disease? Mayo Clin Proc. 2015;90(9):1207–1216. doi:10.1016/j.mayocp.2015.05.020.
   PubMed Web of Science ®Google Scholar
• El-Eshmawy MM,Ibrahim A,Bahriz R, et al. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women. BMC Endocr Disord. 2022;22(1):315.doi:10.1186/s12902-022-01240-y
   PubMed Web of Science ®Google Scholar